Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.

MLA

Shinkai, Masayuki, et al. “Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.” Anticancer Research, vol. 38, no. 10, Oct. 2018, pp. 5975–81. EBSCOhost, https://doi.org/10.21873/anticanres.12945.

APA

Shinkai, M., Imano, M., Chiba, Y., Hiraki, Y., Kato, H., Iwama, M., Shiraishi, O., Yasuda, A., Tsubaki, M., Nishida, S., Kimura, Y., & Yasuda, T. (2018). Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial. Anticancer Research, 38(10), 5975–5981. https://doi.org/10.21873/anticanres.12945

Chicago

Shinkai, Masayuki, Motohiro Imano, Yasutaka Chiba, Yoko Hiraki, Hiroaki Kato, Mitsuru Iwama, Osamu Shiraishi, et al. 2018. “Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.” Anticancer Research 38 (10): 5975–81. doi:10.21873/anticanres.12945.